Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasm Metastasis × Celecoxib × Clear all

Phase

Status

Terminated 7 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Colorectal Neoplasms 5 Head and Neck Neoplasms 4 Colonic Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Tongue Neoplasms 1 Spondylitis, Ankylosing 1 Recurrence 1 Rectal Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Hand-Foot Syndrome 1 Endometrial Neoplasms 1 Colon Cancer Stage 1 Bile Duct Neoplasms 1

Interventions

Fluorouracil 18 Oxaliplatin 15 Capecitabine 15 Leucovorin 13 Irinotecan 11 Gemcitabine 11 Drug Therapy 11 Cetuximab 10 Radiosurgery 9 Cisplatin 9 Bevacizumab 9 Docetaxel 8 Radiotherapy 6 Paclitaxel 6 Neoadjuvant Therapy 6 Everolimus 6 spartalizumab 5 pembrolizumab 5 Trastuzumab 5 Sunitinib 5 S 1 (combination) 5 Cyclophosphamide 5 Chemotherapy, Adjuvant 5 Carboplatin 5 manganese chloride 4 Surgical Procedures, Operative 4 Sorafenib 4 Nivolumab 4 Immunotherapy 4 Immune Checkpoint Inhibitors 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03864575 2019-07-12

NICE-COMBO

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase 2 Unknown

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡